BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

World's Leading Developer Of Neuroperformance And Dyslexia Technology, Epoch Innovations, Raises Additional $6M


10/19/2005 5:10:24 PM

SAN FRANCISCO, March 10 /PRNewswire/ -- Epoch Innovations, the world's leading neuroperformance company, raised $6 million today in its latest round of funding. This round of funding was led by Clarium Capital's Peter Thiel, the co-founder and former CEO of PayPal.

Epoch Innovations develops sophisticated technology solutions to improve cognitive performance. The company's first product, BrightStar, is focused on the multi-billion dollar dyslexia market.

BrightStar has proven highly effective in helping both children and adults with dyslexia. The BrightStar technology uses visual stimuli to aid communication between neural pathways and the cerebellum. Scientific results of the technology show significant improvement in the main literacy areas of reading, writing and spelling. Epoch's BrightStar product is offered at two centers in the U.K., with a third opening in Palo Alto, California in April 2004. Over the next 24 months, Epoch will open five additional centers in the U.S.

Epoch Innovations has experienced rapid growth, with revenues increasing an average of 25 percent month on month for the last year. Epoch Innovations recently formed a major strategic partnership that will provide distribution of BrightStar across the United States. Post money valuation of the most recent round of financing is $33 million, a company spokesperson confirmed. Epoch Innovations will use the additional funds to expand the number of U.S. centers, open up new distribution channels for BrightStar and to develop its next generation of products.

Epoch's BrightStar technology has a wide range of cognitive applications that also extend beyond dyslexia -- including Alzheimer's, Parkinson's, and Autism. Epoch Innovations has been featured on CNN and the London-based BBC.

Founded in 1999, the San Francisco-based company has raised $15 million to date.

Epoch Innovations

CONTACT: Brad Selby, Director, Marketing of Epoch Innovations,+1-415-321-3449, or bselby@epochinv.com




   
Dyslexia

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES